Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...
We recently published 10 Stocks Lighting Up Market Ahead of Christmas. Dynavax Technologies Corp. (NASDAQ:DVAX) is one of the best performers on Wednesday. Dynavax soared by 38.19 percent on Wednesday ...
If you are wondering whether Dynavax Technologies at around $15 a share is still good value after its run, you are not alone. We are going to unpack that in a structured way. The stock has surged 42.5 ...
Zacks Investment Research on MSN

Company news for Dec 26, 2025

Shares of NVIDIA Corp. (NVDA) fell 0.3% following news that the company is planning to acquire assets from Groq, a designer of high-performance AI accelerator chips, for $20 billion in cash. NIKE Inc.
Sanofi announced that it has entered into an agreement to acquire Dynavax Technologies Corporation (Dynavax), a publicly traded vaccines company with a marketed adult hepatitis B vaccine (Heplisav-B) ...
SANOFI said on Wednesday it will buy US biotech Dynavax Technologies for around $2.2 billion (1.9 billion euros) in an agreed deal that will add an adult hepatitis B vaccine and a promising ...
Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas. Shares ...
Dow Jones Top Company Headlines at 3 AM ET: Nike's Revival of Classic Brand Has a Hitch-Soccer Coach Grabbed the Trademark | Even ... Nike's Revival of Classic Brand Has a Hitch-Soccer Coach Grabbed ...
The US stock market rallied, with the S&P 500 hitting a record high as investors anticipate potential interest rate cuts by ...
The Unacademy episode is a sectoral stress test highlighting the need for more specific ESOP frameworks. Aimtron operates ...
The Dow Jones Industrial Average ​rose ‌288.75 points, or 0.60%, to 48,731.16, ‍the S&P 500 gained 22.26 points, ⁠or 0.32%, to 6,932.05 and the Nasdaq Composite gained 51.46 points, or 0.22%, to ...